Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbohydrate Antigen 19-9 Plus Carcinoembryonic Antigen for Prognosis in Colorectal Cancer

NCT04999072 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT04999072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbohydrate Antigen 19-9 Plus Carcinoembryonic Antigen for Prognosis in Colorectal Cancer
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 19, 2020
Completion date
December 1, 2021
Enrollment
4,972 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer